Indraprastha Medical Corporation Limited

Web: delhi.apollohospitals.com NSE: INDRAMEDCO BSE: 532150 SECTOR: Healthcare - Healthcare Services | Add Note | View Notes

354 2(-1%)

Near 52W Low of 342

Volume

5L as on 23, Jun

Open

478

High

488

Low

476

356

VWAP

400

52 Week High

641

52 Week Low

342

Viand Research Rating

Quality Score

46/100

Growth Score

40/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

3,248

No. of Shares

9.17

P/E

26.98

P/B

8.35

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

30.93

ROCE

Profit Growth

Listing Date

17-Apr-97

Promoter Holding

51%

FII Holding

2.43%

DII Holding

0.87%

Price Chart

Price Performance

1 Week3%

1 Month10%

3 Months7%

6 Months2%

1 Year2%

YTD2%

Moving Average

5 Day SMA387

10 Day SMA384

20 Day SMA386

30 Day SMA381

50 Day SMA395

61 Day SMA396

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	416	399	407	421
Resistance 2	407	397	401	409
Resistance 1	401	396	398	406
Pivot Point	392	395	392	394
Support 1	386	393	386	391
Support 2	377	392	383	379
Support 3	371	390	377	376

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 51.00%	(0.01) 51.00%	(0.01) 51.00%	(0.01) 51.00%	(0.01) 51.00%	(0.01) 51.00%	(0.01) 51.00%	(0.01) 51.00%	(0.01) 51.00%	(0.01) 51.00%	(0.01) 51.00%	(0.01) 51.00%	(0.01) 51.00%	(0.01) 51.00%	(0.01) 51.00%	(0.01) 51.00%	(0.01) 51.00%	(0.01) 51.00%	(0.01) 51.00%
FIIs	(-0.31) 2.43%	(0.31) 2.72%	(-0.31) 2.41%	(-0.21) 2.73%	(0.11) 2.94%	(0.21) 2.88%	(0.91) 2.64%	(0.61) 1.70%	(0.11) 1.08%	(0.11) 0.95%	(0.41) 0.81%	(0.11) 0.37%	(-0.51) 0.27%	(0.61) 0.77%	(0.11) 0.15%	(-0.11) 0.09%	(0.01) 0.14%	(0.21) 0.18%	(0.01) 0.03%
DIIs	(0.11) 0.87%	(-2.71) 0.82%	(-0.11) 3.51%	(0.01) 3.56%	(0.41) 3.56%	(0.01) 3.18%	(0.01) 3.19%	(-1.81) 3.14%	(-1.51) 4.91%	(-0.41) 6.36%	(6.71) 6.71%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.02%	(0.01) 0.02%	(0.01) 0.02%	(0.01) 0.02%	(0.01) 0.02%
Public	45.69%	45.43%	43.08%	42.74%	42.50%	42.91%	43.16%	44.14%	43.01%	41.69%	41.49%	48.62%	48.72%	48.22%	48.83%	48.89%	48.84%	48.80%	48.96%
No. of Shareholders	72,980	71,225	70,914	70,211	70,491	69,697	64,671	55,103	54,158	51,448	47,865	48,630	49,833	52,760	55,287	55,290	56,540	57,254	58,001

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	365	372	381	365	334	325	350	348	315	306	317	307	274	277	284	263	216	237	233
Sales Growth % (YoY)	9.3%	14.4%	8.9%	4.9%	6%	6%	10.4%	13.5%	14.8%	10.7%	11.5%	16.4%	27%	17%	22.1%	29.8%	8.9%	31.4%	65.1%
Sales Growth % (QoQ)	-1.9%	-2.4%	4.4%	9.3%	2.8%	-7.1%	0.6%	10.5%	2.9%	-3.5%	3.3%	12%	-1.1%	-2.5%	8%	21.8%	-8.9%	1.7%	-
Expenses	304	310	310	292	272	273	286	281	266	259	267	259	241	240	241	226	188	205	208
Operating Profit	61	62	71	73	61	52	64	67	48	47	50	47	33	37	44	37	28	31	25
OPM %	17	17	19	20	18	16	18	19	15	15	16	15	12	13	15	14	13	13	11
Other Income	7	7	7	7	6	5	6	5	5	4	4	4	5	3	1	1	2	1	0
Interest	1	1	2	2	1	2	2	2	2	1	1	1	1	1	1	1	1	1	1
Depreciation	11	11	11	10	11	11	11	11	10	10	10	10	10	10	10	10	9	9	9
Profit before tax	55	56	66	68	55	45	57	60	42	41	44	40	27	29	34	27	20	22	16
Tax %	24	27	25	25	26	26	26	25	25	28	25	24	27	29	26	24	24	28	26
Net Profit	42	41	49	51	41	33	42	45	31	29	33	30	20	21	25	20	15	16	12
Net Profit Growth % (QoQ)	2.4%	-16.3%	-3.9%	24.4%	24.2%	-21.4%	-6.7%	45.2%	6.9%	-12.1%	10%	50%	-4.8%	-16%	25%	33.3%	-6.2%	33.3%	-
Net Profit Growth % (YoY)	2.4%	24.2%	16.7%	13.3%	32.3%	13.8%	27.3%	50%	55%	38.1%	32%	50%	33.3%	31.2%	108.3%	-	-	-	-
TTM Net Profit	183	182	174	167	161	151	147	138	123	112	104	96	86	81	76	63	43	28	0
EPS in Rs	4.55	4.47	5.4	5.61	4.47	3.58	4.63	4.88	3.4	3.21	3.58	3.33	2.16	2.28	2.74	2.21	1.66	1.74	1.32

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	1483	1356	1245	1099	888	613	831	788	753	766	755	714	678	607
Sales Growth %	9.3%	9%	13.3%	23.7%	44.8%	-26.2%	5.4%	4.7%	-1.7%	1.4%	5.7%	5.4%	11.7%	16.3%
Expenses	1216	1112	1050	947	768	572	743	706	678	686	675	630	587	528
Operating Profit	267	245	195	152	120	41	87	82	74	79	80	85	91	79
OPM %	18	18	16	14	14	7	11	10	10	10	11	12	13	13
Other Income	29	22	16	9	-3	0	0	-1	-1	0	1	1	1	1
Interest	6	6	4	4	3	3	6	7	9	8	7	8	10	9
Depreciation	44	44	40	39	35	33	33	30	31	31	35	28	28	26
Profit before tax	246	216	166	117	79	4	48	45	34	41	39	50	54	45
Tax %	25	26	25	26	26	46	9	36	38	36	37	34	35	37
Net Profit	184	161	124	86	59	2	44	28	21	26	24	32	35	29
Net Profit Growth %	14.3%	29.8%	44.2%	45.8%	2850%	-95.5%	57.1%	33.3%	-19.2%	8.3%	-25%	-8.6%	20.7%	-
EPS in Rs	20.03	17.56	13.52	9.4	6.39	0.25	4.76	3.1	2.3	2.86	2.66	3.54	3.87	3.14
Dividend Payout %	20	26	33	32	39	0	0	52	65	63	68	51	47	51

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	167	157	200	144	94	27	86	75	48	28	62	64	58	67
Cash from Investing Activity	-178	-111	-158	-108	-74	-19	-40	-17	-30	-22	-33	-29	-22	-54
Cash from Financing Activity	-46	-46	-32	-26	-3	-3	-43	-44	-17	-5	-30	-35	-36	-13
Net Cash Flow	-57	0	9	11	17	5	4	14	1	0	0	0	0	0

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	92	92	92	92	92	92	92	92	92	92	92	92	92	92	92	92
Reserves	649	567	505	433	386	288	234	181	176	152	141	139	132	103	95	79
Borrowings	37	31	33	33	34	2	5	3	4	21	66	67	52	50	63	73
Other Liabilities	214	264	222	249	212	173	131	157	177	157	134	160	185	196	199	194
Total Liabilities	991	954	852	806	723	555	462	432	449	422	432	458	460	442	449	438
Fixed Assets	365	351	328	341	347	275	277	283	303	280	294	296	301	286	293	300
CWIP	3	2	33	0	0	3	0	3	0	1	0	0	3	3	2	0
Investments	0	39	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	624	563	491	465	376	278	185	145	146	141	138	163	157	153	154	138
Total Assets	991	954	852	806	723	555	462	432	449	422	432	458	460	442	449	438

Delivery

Delivery Data: INDRAMEDCO

#	Date	348 17% 406	Value (Cr)	Q/T 47	Del 42	Del 18
1	4-Sep	350	11	66	67	7
2	3-Sep	356	5	40	55	3
3	2-Sep	352	10	40	53	6
4	1-Sep	358	10	26	52	5
5	31-Aug	363	6	34	63	4
6	28-Aug	368	4	15	60	3
7	27-Aug	369	3	29	58	2
8	26-Aug	369	4	31	58	2
9	25-Aug	373	6	29	44	3
10	24-Aug	372	6	29	52	3
11	21-Aug	370	5	31	61	3
12	20-Aug	377	6	29	46	3
13	19-Aug	374	14	31	47	6
14	18-Aug	369	5	35	68	3
15	17-Aug	370	4	33	62	3
16	14-Aug	373	6	31	59	3
17	13-Aug	372	7	28	66	4
18	12-Aug	377	8	38	64	5
19	11-Aug	384	12	40	55	7
20	10-Aug	391	21	50	42	9
21	7-Aug	381	332	62	11	35
22	6-Aug	362	8	39	65	5
23	5-Aug	368	4	36	64	3
24	4-Aug	370	9	49	50	5
25	3-Aug	369	4	35	59	3
26	31-Jul	366	4	27	66	3
27	30-Jul	360	3	35	60	2
28	29-Jul	363	16	79	74	12
29	28-Jul	369	3	23	63	2
30	27-Jul	369	4	38	49	2
31	24-Jul	365	4	26	59	2
32	23-Jul	367	3	35	72	2
33	22-Jul	367	3	30	66	2
34	21-Jul	374	4	41	63	3
35	20-Jul	375	5	28	64	3
36	17-Jul	371	4	32	54	2
37	16-Jul	374	3	19	60	2
38	15-Jul	377	3	25	59	2
39	14-Jul	374	3	24	53	2
40	13-Jul	379	4	35	47	2
41	10-Jul	381	3	27	56	2
42	9-Jul	380	4	32	58	2
43	8-Jul	370	5	34	67	3
44	7-Jul	379	5	38	61	3
45	6-Jul	381	8	26	56	4
46	3-Jul	389	3	21	64	2
47	2-Jul	390	4	23	56	2
48	1-Jul	387	4	27	64	3
49	30-Jun	388	7	35	47	3
50	29-Jun	380	5	35	58	3

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	3,248c	6c	0.18
03-Sep	3,254c	67c	2.03
01-Sep	3,322c	35c	1.04
31-Aug	3,357c	19c	0.57
27-Aug	3,376c	45c	1.31
26-Aug	3,421c	6c	0.19
25-Aug	3,414c	5c	0.15
24-Aug	3,419c	15c	0.43
21-Aug	3,434c	92L	0.03
19-Aug	3,433c	60c	1.77
18-Aug	3,374c	15c	0.43
17-Aug	3,388c	31c	0.91
14-Aug	3,419c	28c	0.81
13-Aug	3,447c	13c	0.38
12-Aug	3,461c	115c	3.21
11-Aug	3,575c	0	0
10-Aug	3,575c	244c	7.33
06-Aug	3,331c	61c	1.80
05-Aug	3,392c	17c	0.48
04-Aug	3,408c	59c	1.77
31-Jul	3,349c	28c	0.84
30-Jul	3,321c	4c	0.11
29-Jul	3,318c	74c	2.19
28-Jul	3,392c	10c	0.28
27-Jul	3,382c	0	0

Stock Checklist

Price is above from 52 week high low average: 4%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 4 fund scheme(s) across 2 fund house(s) as of Aug26 · Total value ₹0 Cr · 0 increasing / 2 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	2	0.10%	-0.02%	0
Motilal Oswal Mutual Fund	2	0.00%	-	0

Indraprastha Medical Corporation Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements